Date: 2012-07-30
Type of information: Fundraising
Company: Vaccibody (Norway)
Investors: The Norwegian Radium Hospital Research Foundation (Norway) - Sarsia Seed (Norway) - additional 9 investors
Amount: 875 000 €
Funding type: share issue
Planned used:
Others: The Norwegian Radium Hospital Research Foundation and Sarsia Seed together invested € 760 000 and additional 9 investors added € 115 000 in the share issue held June 28th.
Therapeutic area: Infectious diseases
